Thomas McCoy Roberts, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Polyomavirus Transforming | 27 | 2016 | 280 | 3.400 |
Why?
|
| Helminth Proteins | 12 | 2012 | 178 | 2.930 |
Why?
|
| Phosphatidylinositol 3-Kinases | 40 | 2022 | 2936 | 2.670 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 18 | 2021 | 908 | 2.470 |
Why?
|
| Ascaris | 7 | 2012 | 25 | 2.200 |
Why?
|
| Sperm Motility | 7 | 2012 | 248 | 1.980 |
Why?
|
| Polyomavirus | 12 | 2016 | 253 | 1.970 |
Why?
|
| Spermatozoa | 9 | 2012 | 630 | 1.810 |
Why?
|
| PTEN Phosphohydrolase | 14 | 2022 | 1158 | 1.610 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 4 | 2020 | 78 | 1.590 |
Why?
|
| Cytoskeleton | 11 | 2012 | 1221 | 1.340 |
Why?
|
| Ascaris suum | 5 | 2008 | 11 | 1.250 |
Why?
|
| Protein Phosphatase 2 | 9 | 2016 | 224 | 1.130 |
Why?
|
| Cell Transformation, Neoplastic | 22 | 2017 | 3006 | 1.110 |
Why?
|
| Signal Transduction | 60 | 2022 | 23950 | 1.080 |
Why?
|
| Antigens, Viral, Tumor | 7 | 2014 | 158 | 1.000 |
Why?
|
| Adaptor Proteins, Signal Transducing | 11 | 2018 | 3026 | 0.970 |
Why?
|
| Cell Transformation, Viral | 11 | 2016 | 672 | 0.970 |
Why?
|
| Tankyrases | 1 | 2022 | 13 | 0.940 |
Why?
|
| Proto-Oncogene Proteins | 31 | 2014 | 4677 | 0.880 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2012 | 79 | 0.860 |
Why?
|
| Pseudopodia | 5 | 2009 | 197 | 0.820 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2021 | 676 | 0.800 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 397 | 0.700 |
Why?
|
| Proto-Oncogene Proteins c-raf | 16 | 2010 | 206 | 0.700 |
Why?
|
| Simian virus 40 | 11 | 2014 | 316 | 0.690 |
Why?
|
| Protein-Tyrosine Kinases | 30 | 2008 | 2461 | 0.680 |
Why?
|
| 3T3 Cells | 17 | 2014 | 1126 | 0.670 |
Why?
|
| Phosphorylation | 45 | 2019 | 8720 | 0.650 |
Why?
|
| Animals | 132 | 2023 | 170486 | 0.620 |
Why?
|
| Phosphoproteins | 12 | 2016 | 2550 | 0.600 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2016 | 250 | 0.580 |
Why?
|
| Neoplasms | 16 | 2022 | 20172 | 0.570 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 732 | 0.570 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2013 | 117 | 0.560 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 212 | 0.560 |
Why?
|
| Isoenzymes | 6 | 2014 | 1812 | 0.550 |
Why?
|
| Mice | 73 | 2023 | 80876 | 0.540 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2017 | 1632 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2017 | 2593 | 0.530 |
Why?
|
| Protein Kinases | 11 | 2009 | 1680 | 0.520 |
Why?
|
| Cell Movement | 8 | 2005 | 5489 | 0.510 |
Why?
|
| Morpholines | 5 | 2019 | 572 | 0.500 |
Why?
|
| Aminopyridines | 5 | 2019 | 531 | 0.480 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2014 | 2971 | 0.480 |
Why?
|
| Phosphoprotein Phosphatases | 4 | 2006 | 346 | 0.470 |
Why?
|
| Gene Targeting | 1 | 2016 | 915 | 0.450 |
Why?
|
| src Homology Domains | 5 | 2003 | 372 | 0.450 |
Why?
|
| Tyrosine | 12 | 2003 | 1477 | 0.450 |
Why?
|
| Zebrafish | 7 | 2010 | 3038 | 0.430 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2011 | 110 | 0.410 |
Why?
|
| Neuropeptides | 1 | 2016 | 929 | 0.400 |
Why?
|
| Prostatic Neoplasms | 6 | 2014 | 10525 | 0.390 |
Why?
|
| Amino Acid Sequence | 31 | 2016 | 14215 | 0.380 |
Why?
|
| Enzyme Activation | 17 | 2019 | 3879 | 0.380 |
Why?
|
| Oncogenes | 8 | 2000 | 1244 | 0.370 |
Why?
|
| Platelet-Derived Growth Factor | 11 | 2001 | 643 | 0.370 |
Why?
|
| Cell Survival | 7 | 2015 | 6156 | 0.370 |
Why?
|
| Phosphatidylinositol 3-Kinase | 3 | 2019 | 139 | 0.360 |
Why?
|
| Molecular Sequence Data | 32 | 2007 | 18748 | 0.360 |
Why?
|
| Retroviridae | 7 | 2003 | 957 | 0.360 |
Why?
|
| Cell Membrane | 4 | 2016 | 3892 | 0.360 |
Why?
|
| Protein Kinase Inhibitors | 10 | 2019 | 5405 | 0.350 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2003 | 488 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2012 | 603 | 0.340 |
Why?
|
| Cell Line, Tumor | 19 | 2023 | 16959 | 0.340 |
Why?
|
| Breast Neoplasms | 11 | 2022 | 19800 | 0.330 |
Why?
|
| Cell Line | 39 | 2021 | 16657 | 0.330 |
Why?
|
| Zebrafish Proteins | 3 | 2010 | 1057 | 0.330 |
Why?
|
| Nuclear Proteins | 5 | 2017 | 5982 | 0.320 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 623 | 0.320 |
Why?
|
| Virulence Factors | 1 | 2011 | 514 | 0.320 |
Why?
|
| Mammary Glands, Human | 2 | 2005 | 206 | 0.310 |
Why?
|
| Aging | 2 | 2021 | 8358 | 0.310 |
Why?
|
| Mutagenesis, Insertional | 2 | 2008 | 667 | 0.310 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2007 | 2926 | 0.310 |
Why?
|
| Gene Amplification | 1 | 2011 | 1087 | 0.310 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3645 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 1004 | 0.290 |
Why?
|
| Precipitin Tests | 11 | 2004 | 889 | 0.290 |
Why?
|
| Spermatids | 1 | 2005 | 35 | 0.290 |
Why?
|
| Drug Delivery Systems | 3 | 2016 | 2277 | 0.280 |
Why?
|
| Proto-Oncogenes | 6 | 1994 | 328 | 0.280 |
Why?
|
| Nematoda | 1 | 2005 | 31 | 0.280 |
Why?
|
| Cell Differentiation | 10 | 2016 | 11718 | 0.280 |
Why?
|
| Hematopoiesis | 4 | 2019 | 2015 | 0.280 |
Why?
|
| Phosphotransferases | 6 | 1992 | 311 | 0.280 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 7 | 2000 | 99 | 0.270 |
Why?
|
| Molecular Targeted Therapy | 4 | 2016 | 2878 | 0.260 |
Why?
|
| Ovarian Neoplasms | 5 | 2023 | 4712 | 0.260 |
Why?
|
| Mutation | 20 | 2021 | 29262 | 0.250 |
Why?
|
| Spermatogenesis | 1 | 2005 | 263 | 0.250 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1994 | 375 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2018 | 2118 | 0.250 |
Why?
|
| Transcription Factors | 14 | 2016 | 12005 | 0.250 |
Why?
|
| Fibroblasts | 11 | 2016 | 4299 | 0.240 |
Why?
|
| Retinoblastoma Protein | 3 | 2007 | 706 | 0.240 |
Why?
|
| Molecular Weight | 11 | 2005 | 2440 | 0.240 |
Why?
|
| Phthalazines | 4 | 2018 | 357 | 0.240 |
Why?
|
| Cell Division | 11 | 2004 | 4752 | 0.240 |
Why?
|
| Carrier Proteins | 5 | 2018 | 5141 | 0.230 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 1997 | 502 | 0.230 |
Why?
|
| Schwann Cells | 2 | 2001 | 208 | 0.230 |
Why?
|
| Drug Resistance, Neoplasm | 9 | 2019 | 5197 | 0.230 |
Why?
|
| ras Proteins | 4 | 2014 | 1116 | 0.230 |
Why?
|
| Oncogene Proteins | 2 | 2006 | 759 | 0.230 |
Why?
|
| Prostate | 3 | 2022 | 1564 | 0.220 |
Why?
|
| Embryonic Structures | 1 | 2001 | 7 | 0.220 |
Why?
|
| Multiprotein Complexes | 3 | 2018 | 1162 | 0.220 |
Why?
|
| Cyclins | 1 | 2004 | 595 | 0.220 |
Why?
|
| Lysine | 5 | 2016 | 1026 | 0.220 |
Why?
|
| Notochord | 1 | 2001 | 40 | 0.220 |
Why?
|
| Phenylthiohydantoin | 2 | 2013 | 192 | 0.220 |
Why?
|
| Apoptosis | 7 | 2016 | 10085 | 0.220 |
Why?
|
| Protein Isoforms | 4 | 2020 | 1712 | 0.220 |
Why?
|
| Membrane Proteins | 5 | 2018 | 8072 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 1400 | 0.220 |
Why?
|
| Cell Cycle | 9 | 2019 | 3014 | 0.210 |
Why?
|
| Cyclin D1 | 2 | 2001 | 470 | 0.210 |
Why?
|
| Enzyme Inhibitors | 8 | 2019 | 3936 | 0.210 |
Why?
|
| ADP-Ribosylation Factor 1 | 2 | 2016 | 48 | 0.210 |
Why?
|
| Humans | 93 | 2023 | 708843 | 0.210 |
Why?
|
| Histones | 5 | 2016 | 2579 | 0.210 |
Why?
|
| Protein Biosynthesis | 4 | 2018 | 2164 | 0.210 |
Why?
|
| Receptor, erbB-2 | 7 | 2019 | 2307 | 0.210 |
Why?
|
| DNA, Complementary | 7 | 2018 | 2100 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 8638 | 0.200 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 957 | 0.200 |
Why?
|
| Genes, Switch | 1 | 2000 | 46 | 0.200 |
Why?
|
| Transcription, Genetic | 6 | 2021 | 7965 | 0.200 |
Why?
|
| Antineoplastic Agents | 7 | 2019 | 13714 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 7 | 2014 | 1667 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2012 | 275 | 0.200 |
Why?
|
| Binding Sites | 13 | 2005 | 6276 | 0.200 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2017 | 1095 | 0.200 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2014 | 384 | 0.190 |
Why?
|
| Protein Binding | 13 | 2008 | 9639 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 1200 | 0.190 |
Why?
|
| Receptor Cross-Talk | 1 | 1999 | 124 | 0.190 |
Why?
|
| cdc25 Phosphatases | 1 | 1999 | 67 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2006 | 1461 | 0.190 |
Why?
|
| Carcinoma | 1 | 2011 | 2307 | 0.190 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2014 | 1777 | 0.180 |
Why?
|
| Phenylenediamines | 1 | 2019 | 91 | 0.180 |
Why?
|
| Genes, ras | 5 | 2014 | 719 | 0.180 |
Why?
|
| Myristic Acid | 4 | 2005 | 49 | 0.180 |
Why?
|
| Cells, Cultured | 16 | 2016 | 20170 | 0.180 |
Why?
|
| BRCA1 Protein | 3 | 2022 | 1039 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2010 | 3878 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2010 | 1321 | 0.170 |
Why?
|
| GTPase-Activating Proteins | 1 | 2001 | 495 | 0.170 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2016 | 94 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 6 | 2012 | 3972 | 0.170 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1920 | 0.170 |
Why?
|
| Tumor Virus Infections | 2 | 2016 | 453 | 0.170 |
Why?
|
| Epithelial Cells | 5 | 2017 | 3690 | 0.160 |
Why?
|
| Spodoptera | 5 | 1999 | 160 | 0.160 |
Why?
|
| Actins | 5 | 2007 | 2191 | 0.160 |
Why?
|
| Proteins | 7 | 2018 | 6151 | 0.160 |
Why?
|
| Substrate Specificity | 5 | 2016 | 1897 | 0.160 |
Why?
|
| Phosphotyrosine | 8 | 2009 | 473 | 0.160 |
Why?
|